EP3834824
MEÐFERÐ VIÐ ESTRÓGENVIÐTÆKAJÁKVÆÐU BRJÓSTAKRABBAMEINI MEÐ VALTÆKUM ESTRÓGENVIÐTÆKJAMÓTARA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.3.2015EP published:
22.10.2025EP application number:
21151737.0
EP translation filed:
26.11.2025Grant published:
15.12.2025EPO information:
European Patent Register
Max expiry date:
27.3.2035Expiry date:
27.3.2027Next due date:
31.3.2027
Title in English:
TREATMENT OF AN ESTROGEN RECEPTOR POSITIVE BREAST CANCER USING A SELECTIVE ESTROGEN RECEPTOR MODULATORLanguage of the patent:
English
Timeline
Today
28.3.2015EP application
22.10.2025EP Publication
26.11.2025Translation submitted
15.12.2025Registration published
27.3.2027Expires
Owner
Name:
Duke UniversityAddress:
2812 Erwin Road, Suite 306, Durham, NC 27705, US
Inventor
Name:
WARDELL, Suzanne, E.Address:
Durham, NC 27710, US
Name:
NELSON, Erik, R.Address:
Urbana, IL 61801, US
Name:
MCDONNELL, Donald, P.Address:
Durham, NC 27710, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201461971627 PDate:
28.3.2014Country:
US
Number:
201414512061Date:
10.10.2014Country:
US
Number:
201562129379 PDate:
6.3.2015Country:
US
Classification
Categories:
A61K 31/137, A61K 45/06, A61P 35/04, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 27.3.2026
Expires: 27.3.2027
Payer: Árnason Faktor ehf.